Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy

Wei Wang^{1

2}, Yukai He³, Sha Wu⁴

Affiliations

¹ Department of Obstetrics & Gynecology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
² Department of Obstetrics & Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.
³ Georgia Cancer Center, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
⁴ Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangdong Provincial Key Laboratory of Proteomics, Guangzhou, Guangdong, PR China.

Review

Wei Wang et al. Future Oncol. 2018 Oct.

. 2018 Oct;14(24):2433-2436.

doi: 10.2217/fon-2018-0238. Epub 2018 Aug 24.

Wei Wang^{1

2}, Yukai He³, Sha Wu⁴

¹ Department of Obstetrics & Gynecology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
² Department of Obstetrics & Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.
³ Georgia Cancer Center, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
⁴ Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangdong Provincial Key Laboratory of Proteomics, Guangzhou, Guangdong, PR China.

No abstract available

Keywords: CD8+ T cells; stemness; tumor immunotherapy.

Publication types